Tags

Type your tag names separated by a space and hit enter

[Methylglucamine antimoniate and sodium stibogluconate in the treatment of leishmaniasis. Study of 16 cases].
Pathol Biol (Paris). 1985 Jun; 33(5 Pt 2):607-10.PB

Abstract

Treatment of visceral and cutaneous leishmaniasis rests on pentavalent antimonial drugs. However, side effects are often a problem and resistance may emerge. N-methyl-glucamine given for kala-azar induced hematologic or hepatic toxicity in three patients and failed in two. Four patients with cutaneous leishmaniasis recovered but two exhibited adverse side effects. Sodium stibo-gluconate failed in one of three kala-azar patients and in one of two patients with cutaneous leishmaniasis. The effects of these two drugs are discussed, as well as indications of pentamidine and splenectomy.

Authors

No affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

fre

PubMed ID

3003657

Citation

Bourée, P, et al. "[Methylglucamine Antimoniate and Sodium Stibogluconate in the Treatment of Leishmaniasis. Study of 16 Cases]." Pathologie-biologie, vol. 33, no. 5 Pt 2, 1985, pp. 607-10.
Bourée P, Anciaux ML, Taugourdeau P. [Methylglucamine antimoniate and sodium stibogluconate in the treatment of leishmaniasis. Study of 16 cases]. Pathol Biol (Paris). 1985;33(5 Pt 2):607-10.
Bourée, P., Anciaux, M. L., & Taugourdeau, P. (1985). [Methylglucamine antimoniate and sodium stibogluconate in the treatment of leishmaniasis. Study of 16 cases]. Pathologie-biologie, 33(5 Pt 2), 607-10.
Bourée P, Anciaux ML, Taugourdeau P. [Methylglucamine Antimoniate and Sodium Stibogluconate in the Treatment of Leishmaniasis. Study of 16 Cases]. Pathol Biol (Paris). 1985;33(5 Pt 2):607-10. PubMed PMID: 3003657.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Methylglucamine antimoniate and sodium stibogluconate in the treatment of leishmaniasis. Study of 16 cases]. AU - Bourée,P, AU - Anciaux,M L, AU - Taugourdeau,P, PY - 1985/6/1/pubmed PY - 1985/6/1/medline PY - 1985/6/1/entrez SP - 607 EP - 10 JF - Pathologie-biologie JO - Pathol Biol (Paris) VL - 33 IS - 5 Pt 2 N2 - Treatment of visceral and cutaneous leishmaniasis rests on pentavalent antimonial drugs. However, side effects are often a problem and resistance may emerge. N-methyl-glucamine given for kala-azar induced hematologic or hepatic toxicity in three patients and failed in two. Four patients with cutaneous leishmaniasis recovered but two exhibited adverse side effects. Sodium stibo-gluconate failed in one of three kala-azar patients and in one of two patients with cutaneous leishmaniasis. The effects of these two drugs are discussed, as well as indications of pentamidine and splenectomy. SN - 0369-8114 UR - https://www.unboundmedicine.com/medline/citation/3003657/[Methylglucamine_antimoniate_and_sodium_stibogluconate_in_the_treatment_of_leishmaniasis__Study_of_16_cases]_ L2 - http://www.diseaseinfosearch.org/result/4166 DB - PRIME DP - Unbound Medicine ER -